bioRxiv Science⌕ Search

Biology subjects

Stiffler, D.

Publications and source records attributed to Stiffler, D..

2 recordsLinked to original sources

GPU-accelerated Dynamic Time Warping for SelectiveNanopore Sequencing

The design and supply of RT-PCR primers for accurate virus testing is a complex process. The MinION is a revolutionary portable nanopore DNA sequencer that may be used to sequence the whole genome of a target virus in a biological sample. Human samples have more than 99% of non-target host DNA and Read Until is a protocol that enables the MinION to selectively eject reads in real-time. However, the MinION does not have any in-built compute power to select non-target reads. SquiggleFilter is a prior work that identified the accuracy and throughput challenges in performing Read Until using the state-of-the-art solution and proposed a hardware-accelerated subsequence Dynamic Time Warping (sDTW) based programmable filter on an ASIC. However, SquiggleFilter does not work for genomes larger than 100Kb. We optimize SquiggleFilters sDTW algorithm onto the more commonly available GPUs. DTWax better uses tensor core pipes, 2X-SIMD FP16 computations and efficient data handling strategies using offline pre-processing, coalesced global memory loads, warp shuffles and shared memory buffering among other optimizations. DTWax enables Read Until and yields 1.92X sequencing speedup and 3.64X compute speedup: costup over a sequencing workflow that does not use Read Until.

bioinformatics↗

Transmissibility of clinically relevant atovaquone-resistant Plasmodium falciparum by anopheline mosquitoes

Rising numbers of malaria cases and deaths underscore the need for new interventions. Long-acting injectable medications, such as those now in use for HIV prophylaxis, offer the prospect of a malaria "chemical vaccine", combining the efficacy of a drug (like atovaquone) with the durability of a biological vaccine. Of concern, however, is the possible selection and transmission of drug-resistant parasites. We addressed this question by generating clinically relevant, highly atovaquone-resistant, Plasmodium falciparum mutants competent to infect mosquitoes. Isogenic paired strains, that differ only by a single Y268S mutation in cytochrome b, were evaluated in parallel in southeast Asian (Anopheles stephensi) or African (Anopheles gambiae) mosquitoes, and thence in humanized mice. Fitness costs of the mutation were evident along the lifecycle, in asexual parasite growth in vitro and in a progressive loss of parasites in the mosquito. In numerous independent experiments, microscopic exam of salivary glands from hundreds of mosquitoes failed to detect even one Y268S sporozoite, a defect not rescued by coinfection with wild type parasites. Furthermore, despite uniformly successful transmission of wild type parasites from An. stephensi to FRG NOD huHep mice bearing human hepatocytes and erythrocytes, multiple attempts with Y268S-fed mosquitoes failed: there was no evidence of parasites in mouse tissues by microscopy, in vitro culture, or PCR. These studies confirm a severe-to-lethal fitness cost of clinically relevant atovaquone-resistant P. falciparum in the mosquito, and they significantly lessen the likelihood of their transmission in the field. SignificanceNew tools are needed to protect individuals from malaria and to control malaria in the field. Atovaquone plus proguanil is a commonly used and well-tolerated medicine to prevent malaria. No drug resistance has been reported from its prophylactic use, but tablets must be taken daily. Giving atovaquone as a single injection may provide much longer-lasting protection, against both falciparum and vivax malaria, but there is concern this may create drug resistance. In this study we showed that clinically relevant atovaquone-resistant malaria parasites survive poorly, if at all, in mosquitoes, and that mosquitoes do not transmit drug-resistant parasites to humanized mice. These findings lessen the likelihood that an atovaquone "chemical vaccine" would lead to the spread of atovaquone resistance.

microbiology↗